CBD 101

How to Read a CBD Certificate of Analysis

A practical guide to matching a CBD product with its lab report, checking cannabinoid amounts and spotting missing information.

CBD 101

A certificate of analysis—usually shortened to COA—is a laboratory report describing what was detected in a tested sample. It can help a shopper verify a label, but only when the report is current, readable and connected to the product in hand.

1. Match the product and batch

Start with the product name, size, batch or lot number and test date. A generic report for raw hemp extract is not the same as a report for the final packaged product. If the label carries a QR code, it should lead directly to useful results rather than a maze of unrelated files.

2. Check the cannabinoid panel

Look for CBD, delta-9 THC and any other cannabinoids claimed on the label. Confirm whether the lab reports amounts by weight, volume, serving or entire package before comparing the result with the bottle or jar.

3. Look beyond potency

A fuller report can include screens for heavy metals, pesticides, residual solvents, microbes and other contaminants. The exact tests and allowable limits can vary by product type and jurisdiction, so a simple “CBD detected” result should not be mistaken for a complete review.

4. Read the dates and laboratory details

The report should identify the testing laboratory, sample dates, methods and status of each result. Old reports, cropped screenshots and documents without a clear laboratory identity deserve extra scrutiny.

5. Watch for these red flags

  • The QR code leads only to the brand homepage.
  • The lot number cannot be matched to the package.
  • The claimed CBD amount and lab result use different measurements with no explanation.
  • Only a cannabinoid panel is shown while the brand describes the report as “full panel.”
  • The report is unreadable, incomplete or missing pages.
Important: A COA is evidence from a laboratory—not FDA approval, a medical recommendation or a promise that a product will produce a particular result.

The FDA continues to caution consumers about unapproved therapeutic claims and inconsistent quality in the CBD market. Read the agency’s current CBD information and regulatory overview.